IBIwona Beń-Skowronek

Iwona Beń-Skowronek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iwona Beń-Skowronek has a total of 263 co-authors. Here are the top co-authors by number of shared publications:

  • Artur Mazur

    College of Medical Sciences, University of Rzeszów, 35-315 Rzeszów, Poland

    7 shared publications
  • Artur Bossowski

    Department of Paediatrics, Endocrinology, Diabetology with Cardiology Division, Medical University of Bialystok, Bialystok, Poland

    6 shared publications
  • Joanna Sieniawska

    Department of Paediatric Endocrinology and Diabetology with Laboratory of Endocrinology and Metabolism, Medical University of Lublin, Poland

    6 shared publications
  • Katarzyna Zorena

    Department of Immunobiology and Environmental Microbiology, Faculty of Health Sciences, Medical University of Gdansk, 80-210 Gdansk, Poland

    6 shared publications
  • Aleksandra Krzewska

    Department of Paediatric Endocrinology and Diabetology with Laboratory of Endocrinology and Metabolism, Medical University of Lublin, Poland

    5 shared publications
  • Leszek Szewczyk

    Department of Paediatric Endocrinology, and Diabetology, Medical University Children Hospital, Lublin, Poland

    5 shared publications

Latest Publications

  • Open Access

    Establishing a Cut-Off Value for Zinc Alpha-2 Glycoprotein in Serum as a Potential Biomarker in Children and Adolescents with Obesity

    by Barbara Siewert, Katarzyna Zorena, Anna Sośnicka, Marta Jaskulak, Iwona Beń-Skowronek

    Zinc-α2-glycoprotein (ZAG) is a novel adipokine with a plethora of functions meaningful for the regulation of adipose tissue and insulin sensitivity. Despite research, the role of ZAG in the course of childhood obesity is not fully understood. The aim of this study is to investigate whether the levels of ZAG can be used as a predictive or monitoring biomarker of adolescent obesity. Secondly, to determine the cut-off value of ZAG in blood serum in adolescents with obesity. The study included a group of 77 adolescent patients, including 59 obese patients, and 18 without obesity as healthy control subjects. All study participants had their biochemical parameters assessed by a certified medical laboratory. The recommendations of the Polish Society of Hypertensions were used to assess the blood pressure measurements in each group. ELISA enzyme immunoassays (R&D Systems, Minneapolis, MN, USA) were used to detect serum levels of ZAG. Our study showed that obese children and adolescents have significantly higher body mass, cholesterol, LDL-cholesterol, triglycerides (TG), systolic blood pressure (SBP) and diastolic blood pressure (DBP), but lower serum ZAG levels compared to the healthy control subjects. Furthermore, in our study, we found that median ZAG values were comparable between females and males within the same obesity category (median female ZAG level: 2.84, median male ZAG level: 2.89) and healthy control participants (median female ZAG level: 5.20, median male ZAG level: 4.99). Serum ZAG concentrations were significantly lower in obese participants (2.86 ± 0.40 mg/L) than in the control group (5.10 ± 0.74 mg/L; p < 0.001). The multivariable Firth’s logistic regression model, incorporating the selected factors, revealed a significant association between obesity and ZAG. ROC curve analysis indicated strong discriminatory ability of ZAG for identifying obesity, with a proposed cut-off value of 3.62 mg/L. Circulating ZAG level is significantly reduced in children and adolescents with obesity. An important finding of our study is the detection of a cutoff value for serum ZAG levels. Furthermore, the use of the Least Absolute Shrinkage and Selection Operator (LASSO) model can be considered a valuable contribution to defining ZAG as an independent factor associated with obesity.

  • Open Access

    Relationship Between Particulate Matter (PM2.5 and PM10), Nitrogen Dioxide (NO2), Sulfur Dioxide (SO2), and the Incidence Rates of Type 1 Diabetes in 2017–2018 Compared to 2020–2021 During the Period of Restrictions Related to the SARS-CoV-2 Pandemic

    by Anna Sośnicka, Marta Jaskulak, Żaklina Tomczyk, Sylwia Krawczyk, Robert Piekarski, Iwona Beń-Skowronek, Katarzyna Zorena

    In recent years, more and more studies have been published on the impact of air pollution on the increase in the incidence of type 1 diabetes mellitus (T1DM) in children and adolescents. To confirm this, we attempted to show whether there are differences between the impact of air pollution in 2017–2018 compared to the impact of air pollution during the lockdown period, i.e., 2020–2021, and its potential relationship with the incidence rates of new cases of T1DM. Methods: We obtained the number of new cases of T1DM in 2017–2018 and 2020–2021 in the Lublin Voivodeship. Data on the annual average concentrations of nitrogen dioxide (NO2), nitric oxides (NOx), sulphur dioxide (SO2) and particulate matter (PM10 and PM2.5) were obtained from Annual Air Quality Assessment reports from 2017–2018 and 2020–2021, made available by the Provincial Inspectorate of Environmental Protection (WIOS) in Lublin. Results: In 2017–2018, air pollution in the entire Lublin Voivodeship was higher than during the lockdown period, i.e., 2020–2021. Moreover, in 2017 and 2018 in the Lublin Voivodeship, strong statistically significant positive correlations were found between NO2 and PM2.5 concentrations and the occurrence of T1DM in children. Conclusions: The research results indicate that air pollution is one of the factors that may suggest a potential association with the development of T1DM. Therefore, every effort should be made to minimize air pollution, which will reduce the risk of developing T1DM and other diseases.

  • Open Access

    Leptin, Interleukin 6, and Vascular Endothelial Growth Factor as Potential Predictors of Primary Hypertension in Children and Adolescents with Obesity

    by Anna Sosnicka, Marta Jaskulak, Izabela Rysz, Malgorzata Grzybowska, Milena Deptuła, Małgorzata Zawrzykraj, Michał Pikuła, Iwona Ben-Skowronek, Katarzyna Zorena

    The increasing prevalence of obesity-related primary arterial hypertension (PAH) in the pediatric population emphasizes the need to develop new biomarkers that can aid in clinical practice for prevention or early diagnosis of the cardiovascular disease. The objective of the present study was to evaluate the relationship between selected adipokines, cytokines, and blood pressure (BP) values in children with obesity. A total of 78 children participated in the study: 60 children with obesity (study group) and 18 children with normal weight (control group). Blood pressure was measured according to guidelines. Serum levels of metabolic and inflammatory markers, including leptin, adiponectin, resistin, ghrelin, interleukin 6 (IL-6), interleukin 10 (IL-10), tumor necrosis factor α (TNF-α), vascular endothelial growth factor (VEGF), and insulin were determined using multiplex immunoassays. Statistical analysis included correlation and ROC tests to identify potential predictors of PAH. The study group had significantly higher systolic and diastolic BP compared to the control group (p < 0.0001). Serum levels of leptin, IL-6, VEGF, insulin, and resistin were increased in the study group. Leptin, IL-6 and resistin correlated positively with BP values (p < 0.05), while ghrelin and adiponectin correlated negatively. ROC analysis identified leptin, IL-6, and VEGF as the most promising biomarkers for predicting PAH. The results confirm the role of adipokines and cytokines in the pathogenesis of PAH. The assessment of adipokine and cytokine profiles complements traditional anthropometric parameters such as BMI in assessing cardiovascular risk. Leptin, IL-6, and VEGF presented the strongest correlation with hypertension, suggesting their potential in future diagnostic and preventive strategies.


  • Open Access

    The strategies of orthodontic treatment in children with growth hormone deficiency

    by Elżbieta Pels, Szymon Krzewski, Aleksandra Krzewska, Iwona Beń-Skowronek, Joanna Wawer, Michał Łobacz

    Introduction and objective: Growth hormone (GH) is crucial for body growth and affects parameters such as bone development. Malocclusions, resulting from discrepancies between the dental arches of the maxilla and mandible, are common in children with growth hormone deficiency (GHD). The study...

  • Open Access

    The Presence of Heavy Metals in Drinking Water and Its Possible Impact on the Development of Type 1 Diabetes in Children

    by Katarzyna Zorena, Małgorzata Michalska, Maria Bartoszewicz, Piotr Wąż, Sylwia Krawczyk, Iwona Beń-Skowronek, Małgorzata Myśliwiec

    This study aimed to determine the relationship between the concentration of heavy metals in drinking water and the number of type 1 diabetes mellitus (T1DM) cases in two regions of Poland. The number of births in 2015-16 in Pomeranian Voivodeship was 50,461, while the number of new T1DM cases was 219. In Lublin Voivodeship, the number of births in the same period reached 39,381, and the number of new T1DM cases was 221. The incidence of T1DM, calculated per 100 live births, amounted to 0.43 and 0.56 in Pomeranian and Lublin. The statistical analysis of collected data proved that the number of new T1DM cases in Pomeranian Voivodeship is correlated to the concentrations of selenium (Se; p < 0.0001), lead (Pb; p < 0.00001), cadmium (Cd; p < 0.00001), zinc (Zn; p < 0.00001) and arsenic (As; p = 0.00001). In the case of Lublin Voivodeship, the number of new T1DM cases was correlated to the concentrations of Se (p = 0.0000001), Pb (p < 0.000001), Cd (p = 0.0000001) and Zn (p < 0.00001) in drinking water. No correlation was found between the number of new T1DM cases and arsenic concentration in the drinking water samples from Lublin Voivodeship. The results indicated that environmental exposure to specific heavy metals may contribute to the risk of T1DM, underscoring the need for stringent environmental controls and public health policies to mitigate these risks.


  • Open Access

    Assessment of the efficacy of vosoritide therapy in children with achondroplasia in clinical trials

    by Wiktoria Wrobel, Iwona Ben-Skowronek

    Assessment of the efficacy of vosoritide therapy in children with achondroplasia in clinical trials


  • Open Access

    IGF-1 and IGF-2 as Molecules Linked to Causes and Consequences of Obesity from Fetal Life to Adulthood: A Systematic Review

    by Justyna Szydlowska-Gladysz, Adrianna Edyta Gorecka, Julia Stepien, Izabela Rysz, Iwona Ben-Skowronek

    This study examines the impact of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor 2 (IGF-2) on various aspects of children’s health—from the realms of growth and puberty to the nuanced characteristics of metabolic syndrome, diabetes, liver pathology, carcinogenic potential, and cardiovascular disorders. A comprehensive literature review was conducted using PubMed, with a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) method employing specific keywords related to child health, obesity, and insulin-like growth factors. This study reveals associations between insulin-like growth factor 1 and birth weight, early growth, and adiposity. Moreover, insulin-like growth factors play a pivotal role in regulating bone development and height during childhood, with potential implications for puberty onset. This research uncovers insulin-like growth factor 1 and insulin-like growth factor 2 as potential biomarkers and therapeutic targets for metabolic dysfunction-associated liver disease and hepatocellular carcinoma, and it also highlights the association between insulin-like growth factors (IGFs) and cancer. Additionally, this research explores the impact of insulin-like growth factors on cardiovascular health, noting their role in cardiomyocyte hypertrophy. Insulin-like growth factors play vital roles in human physiology, influencing growth and development from fetal stages to adulthood. The impact of maternal obesity on children’s IGF levels is complex, influencing growth and carrying potential metabolic consequences. Imbalances in IGF levels are linked to a range of health conditions (e.g., insulin resistance, glucose intolerance, metabolic syndrome, and diabetes), prompting researchers to seek novel therapies and preventive strategies, offering challenges and opportunities in healthcare.


  • Zalecenia diagnostyki zakażenia syncytialnym wirusem oddechowym (RSV) u dzieci. Rekomendacje Polskiego Towarzystwa Pediatrycznego i Konsultanta krajowego w dziedzinie pediatrii

    by Centrum Medyczne Kształcenia Podyplomowego Klinika Pediatrii, Teresa Jackowska, August Wrotek, Łukasz Dembiński, Warszawa Klinika Gastroenterologii i Żywienia Dzieci Warszawskiego Uniwersytetu Medycznego, Tomasz Jarmoliński, Onkologii i Hematologii Dziecięcej Klinika Transplantacji Szpiku, Artur Mazur, Endokrynologii i Diabetologii Dziecięcej Klinika Pediatrii, Tomasz Szczepański, et al.

  • Szczepienia przeciw COVID-19 u dzieci w sezonie 2023/2024 (grudzień 2023). Rekomendacje Polskiego Towarzystwa Pediatrycznego i Konsultanta krajowego w dziedzinie pediatrii

    by Centrum Medyczne Kształcenia Podyplomowego Klinika Pediatrii, Teresa Jackowska, Marcin Rozwadowski, Hanna Czajka, Uniwersytet Rzeszowski Kolegium Nauk Medycznych, August Wrotek, Łukasz Dembiński, Warszawa Klinika Gastroenterologii i Żywienia Dzieci Warszawskiego Uniwersytetu Medycznego, Artur Mazur, Endokrynologii i Diabetologii Dziecięcej Klinika Pediatrii, et al.

  • Open Access

    Case Report: Adrenocortical carcinoma in children—symptoms, diagnosis, and treatment

    by Estera Zagojska, Magdalena Malka, Adrianna Gorecka, Iwona Ben-Skowronek

    Adrenocortical carcinomas are extremely rare in the paediatric population. Most of them are hormone-secretive lesions; therefore, they should be taken into consideration in a child with signs of precocious puberty and/or Cushing’s syndrome symptoms. Nonetheless, differentiation from benign adrenal tumours is necessary. We report a rare case of adrenocortical carcinoma in a girl and a literature review using the PubMed database. A four-year-old girl presented with rapidly progressing precocious puberty and signs of Cushing’s syndrome. Imaging of the abdomen revealed a large heterogeneous solid mass. Histopathologic evaluation confirmed adrenocortical carcinoma with high mitotic activity, atypical mitoses, pleomorphism, necrosis, and vascular invasion. After tumourectomy, a decrease of previously elevated hormonal blood parameters was observed. Genetic tests confirmed Li Fraumeni syndrome. Adrenocortical carcinoma should be suspected in children with premature pubarche and signs of Cushing’s syndrome. Diagnosis must be based on clinical presentation, hormonal tests, imaging, and histopathological evaluation. Complete surgical resection of the tumour is the gold standard. Oncological treatment in children is not yet well-studied and should be individually considered, especially in advanced, inoperable carcinomas with metastases. Genetic investigations are useful for determining the prognosis in patients and their siblings.